Literature DB >> 8562404

Activated protein C sensitivity ratio in pregnant women at delivery.

F Mathonnet1, P de Mazancourt, B Bastenaire, M Morot, N Benattar, S Beufé, J Y Borg, Y Giudicelli.   

Abstract

We studied activated protein C sensitivity ratio (APC-SR), factors V and VIII activity and von Willebrand antigen in control women, women using oral contraceptives, and pregnant women at delivery. The mean APC-SR of 2.4 in pregnant women was significantly lower than the mean APC-SR value of 3.5 for both the other groups and 45% of pregnant women had a ratio below the 5th percentile of the control group. None of them carried the R506-->Q mutation. This decreased ratio at delivery appeared to be connected, at least in part, with increased VIII activity. Thus, APC-SR at delivery should not be used to detect APC resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8562404     DOI: 10.1046/j.1365-2141.1995.00271.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Thrombin generation test as a marker for high risk venous thrombosis pregnancies.

Authors:  Bérangère S Joly; Bénédicte Sudrié-Arnaud; Virginie Barbay; Jeanne-Yvonne Borg; Véronique Le Cam Duchez
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

Review 2.  Thrombophilia in pregnancy.

Authors:  I D Walker
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 3.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

4.  Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma.

Authors:  Divyanu Jain; Tomoaki Oda; Kenta Kawai; Yoshimasa Horikoshi; Masako Matsumoto; Megumi Narumi; Yukiko Kohmura-Kobayashi; Naomi Furuta-Isomura; Chizuko Yaguchi; Toshiyuki Uchida; Kazunao Suzuki; Naohiro Kanayama; Hiroaki Itoh; Naoaki Tamura
Journal:  J Thromb Thrombolysis       Date:  2021-07-06       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.